Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More
Xconomy
JUNE 17, 2016
—The FDA approved a cholera vaccine , Vaxchora, giving Redwood City, CA-based PaxVax its second commercial product. . —Shares of Boston-based Paratek Pharmaceuticals (NASDAQ: PRTK ), meanwhile, surged more than 20 percent after its antibiotic, omadacycline, succeeded in the first of two Phase 3 trials. Reprints | Share:
Let's personalize your content